Moïshe Liberman
Institut universitaire de cardiologie et de pneumologie de Québec · 282 works · 10,799 citations · h-index 44
Top works
- Surgery Decreases Long-term Mortality, Morbidity, and Health Care Use in Morbidly Obese Patients
- Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer
- Lobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung Cancer
- Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer
- LBA56 Overall survival in the KEYNOTE-671 study of perioperative pembrolizumab for early-stage non-small-cell lung cancer (NSCLC)
- Advanced or Basic Life Support for Trauma: Meta-analysis and Critical Review of the Literature
- LBA73 Pathological complete response (pCR) to durvalumab plus 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in resectable gastric and gastroesophageal junction cancer (GC/GEJC): Interim results of the global, phase III MATTERHORN study
- Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503)
- The Impact of Weight Reduction Surgery on Health-Care Costs in Morbidly Obese Patients
- Ten years of experience with third and fourth branchial remnants
- Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer
- The New Injury Severity Score: A More Accurate Predictor of In-Hospital Mortality than the Injury Severity Score
- Surgery residents and attending surgeons have different perceptions of feedback
- Cardiopulmonary resuscitation: errors made by pre-hospital emergency medical personnel
- Multicenter Canadian Study of Prehospital Trauma Care
- Tumours of the thymus: a cohort study of prognostic factors from the European Society of Thoracic Surgeons database
- Emergency Medical Service (EMS) systems in developed and developing countries
- Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial
- International comparison of prehospital trauma care systems
- Impact of waiting time on the quality of life of patients awaiting coronary artery bypass grafting.